Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus

Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus

Aim. To evaluate the impact of combination antihypertensive therapy with lisinopril + amlodipine (Еkvator) on endothelial dysfunction in patients with hypertension and concurrent type 2 diabetes mellitus (T2DM). Subjects and methods. The trial enrolled 30 patients aged 40 to 65 years with Stages II-...

Full description

Bibliographic Details
Main Authors:	M E Statsenko, M V Derevianchenko, O V Ostrovskiĭ, M N Titarenko, M K Shvets, A M Bondarev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-09-01
Series:	Терапевтический архив
Subjects:	endothelial dysfunction combination antihypertensive therapy hypertension type 2 diabetes mellitus
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31341

Similar Items

Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy
by: M E Statsenko, et al.
Published: (2014-08-01)

Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus
by: M E Statsenko, et al.
Published: (2013-12-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2016-03-01)

State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2017-01-01)

State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2017-01-01)

The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension
by: Elfimova E.M., et al.
Published: (2017-02-01)

The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension
by: E M Elfimova, et al.
Published: (2017-03-01)

What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region
by: Y. I. Grinshtein, et al.
Published: (2016-12-01)

The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction
by: Placido Rojas-Franco, et al.
Published: (2022-03-01)

Correction of endothelial dysfunction and microcirculation disturbances in patients with essential arterial hypertension and Type 2 diabetes mellitus
by: N. V. Yakutina
Published: (2007-12-01)

Relationship Between Hypertension, Antihypertensive Drugs and Sexual Dysfunction in Men and Women: A Literature Review
by: Lou IX, et al.
Published: (2023-11-01)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension
by: Tatiana V. Pinchuk, et al.
Published: (2021-02-01)

Analysis of antihypertensive therapy and its adherence in hypertensive patients with and without concomitant diabetes mellitus
by: V A Sergeyeva
Published: (2012-12-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
by: Viktoriya Borisovna Mychka, et al.
Published: (2009-03-01)

ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFECTS OF FOSINOPRILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: N. Yu. Grigorieva, et al.
Published: (2018-01-01)

Features of prescriptions of antihypertensive therapy in patients with diabetes mellitus type 2: Theory and Practice
by: I. А. Zupanets, et al.
Published: (2014-12-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

New-Onset Diabetes, Endothelial Dysfunction, and Cardiovascular Outcomes in Hypertensive Patients: An Illness-Event Model Analysis
by: Raffaele Maio, et al.
Published: (2021-06-01)

Hyperuricemia, endothelial dysfunction and hypertension
by: Daniela MIRICESCU, et al.
Published: (2020-06-01)

Analysis of factors associated with sterile inflammation in women with pe receiving different antihypertensive treatment strategies
by: K. T. Muminova, et al.
Published: (2023-06-01)

Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
by: Cong Zhao, et al.
Published: (2023-06-01)

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

DANGER OF ALCOHOL FOR PATIENTS WITH ARTERIAL HYPERTENSION DURING ANTIHYPERTENSIVE THERAPY
by: M. P. Savenkov, et al.
Published: (2016-01-01)

The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
by: I E Chazova, et al.
Published: (2017-06-01)

Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension
by: I I Chukaeva, et al.
Published: (2017-06-01)

The Relationship of Endothelial Dysfunction with the Development of Diastolic Heart Failure in Patients with Hypertension
by: T. V. Kalinkina, et al.
Published: (2020-07-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Frequency of Iatrogenic Sexual Dysfunction Associated with Antihypertensive Compounds
by: Bárbara Buch-Vicente, et al.
Published: (2021-11-01)

Disfunción endotelial y diabetes mellitus Endothelial dysfunction and diabetes mellitus
by: Jeddú Cruz Hernández, et al.
Published: (2012-08-01)

Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction
by: Tatsuya Maruhashi, et al.
Published: (2021-08-01)

Morpho-functional basis of endothelial dysfunction in diabetes mellitus
by: A. I. Gozhenko, et al.
Published: (2017-06-01)

Morpho-functional basis of endothelial dysfunction in diabetes mellitus
by: A. I. Gozhenko, et al.
Published: (2017-06-01)

Effect of antihypertensive therapy on cognitive functions of patients with hypertension
by: Jaiswal Ashok, et al.
Published: (2010-01-01)

Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management
by: Hernández-Cerda J, et al.
Published: (2020-06-01)

Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension
by: Nihan Kahya Eren, et al.
Published: (2014-12-01)

Hemodynamic effects of combined antihypertensive therapy during exercise in men with arterial hypertension and chronic venous diseases
by: S. V. Letyagina, et al.
Published: (2021-10-01)

Resistant arterial hypertension: problems and opportunities for personalised drug therapy
by: A. V. Fendrikova, et al.
Published: (2020-10-01)

Endothelial cell clonality, heterogeneity and dysfunction in pulmonary arterial hypertension
by: Geoffrey Newcomb, et al.
Published: (2023-12-01)